JPRN-UMIN000036846
Completed
未知
Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan - Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan
ung and Mediastinal Tumor Committee of Japanese Radiation Oncology Study Group (JROSG)0 sites67 target enrollmentMay 27, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ung and Mediastinal Tumor Committee of Japanese Radiation Oncology Study Group (JROSG)
- Enrollment
- 67
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have refused to use data.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study on the treatment of lung cancer related fatigue with deficiency of Qi-blood by traditional Chinese herb medicine combined with AcupunctureITMCTR2000003964Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Active, not recruiting
Not Applicable
Dose radiotherapy for lung cancer treatment.ung cancer.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2010-021382-78-ESConsorci Mar Parc de Salut de Barcelona (Parc de Salut MAR)
Completed
Not Applicable
Treatment of lung cancer - a health care research study using data cancer registry data (registration according to § 65c SGB V)C34Malignant neoplasm of bronchus and lungDRKS00025080niversität zu Lübeck, Institut für Sozialmedizin und Epidemiologie70,804
Completed
Phase 2
Phase II study of thoracic radiotherapy concurrently combined with cisplatin and vinorelbine chemotherapy followed by sequential therapy with TS-1 for inoperable locally advanced non-small cell lung cancerJPRN-UMIN000002381ational Hospital Study Group for Lung Cancer65
Recruiting
Not Applicable
Clinical trial of concurrent chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in patients with locally advanced head and neck squamous cell carcinomaocally advanced head and neck squamous cell carcinomaJPRN-UMIN000021841Yokohama City University hospital50